Agilent Technologies, Inc. (NYSE:A) Shares Purchased by Zurcher Kantonalbank Zurich Cantonalbank

Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 2.4% during the third quarter, HoldingsChannel reports. The fund owned 184,483 shares of the medical research company’s stock after acquiring an additional 4,287 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Agilent Technologies were worth $27,392,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in A. B. Riley Wealth Advisors Inc. lifted its holdings in Agilent Technologies by 47.9% during the 1st quarter. B. Riley Wealth Advisors Inc. now owns 5,281 shares of the medical research company’s stock worth $768,000 after buying an additional 1,711 shares during the last quarter. Atria Investments Inc lifted its stake in Agilent Technologies by 26.6% during the first quarter. Atria Investments Inc now owns 11,841 shares of the medical research company’s stock worth $1,723,000 after purchasing an additional 2,491 shares during the last quarter. Cetera Investment Advisers boosted its holdings in Agilent Technologies by 953.3% in the first quarter. Cetera Investment Advisers now owns 32,694 shares of the medical research company’s stock worth $4,757,000 after purchasing an additional 29,590 shares during the period. Cetera Advisors LLC increased its stake in Agilent Technologies by 45.7% during the first quarter. Cetera Advisors LLC now owns 13,620 shares of the medical research company’s stock valued at $1,982,000 after purchasing an additional 4,274 shares during the last quarter. Finally, EverSource Wealth Advisors LLC raised its holdings in shares of Agilent Technologies by 36.4% during the first quarter. EverSource Wealth Advisors LLC now owns 731 shares of the medical research company’s stock worth $100,000 after purchasing an additional 195 shares during the period.

Agilent Technologies Trading Down 0.1 %

Shares of NYSE:A opened at $137.98 on Friday. Agilent Technologies, Inc. has a twelve month low of $124.16 and a twelve month high of $155.35. The company has a current ratio of 2.09, a quick ratio of 1.37 and a debt-to-equity ratio of 0.57. The firm has a market cap of $39.65 billion, a P/E ratio of 31.22, a P/E/G ratio of 4.38 and a beta of 1.07. The company has a 50 day moving average of $137.60 and a 200-day moving average of $137.37.

Agilent Technologies Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 22nd. Shareholders of record on Tuesday, December 31st will be given a $0.248 dividend. This represents a $0.99 dividend on an annualized basis and a yield of 0.72%. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.24. The ex-dividend date of this dividend is Tuesday, December 31st. Agilent Technologies’s dividend payout ratio is 21.27%.

Insider Buying and Selling at Agilent Technologies

In other Agilent Technologies news, SVP Dominique Grau sold 9,990 shares of the company’s stock in a transaction dated Thursday, September 26th. The shares were sold at an average price of $145.00, for a total value of $1,448,550.00. Following the completion of the sale, the senior vice president now directly owns 40,011 shares of the company’s stock, valued at approximately $5,801,595. This represents a 19.98 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Analysts Set New Price Targets

A has been the subject of a number of recent research reports. StockNews.com downgraded shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research report on Tuesday. UBS Group increased their price target on Agilent Technologies from $141.00 to $150.00 and gave the stock a “neutral” rating in a research report on Thursday, August 22nd. Barclays cut their price target on Agilent Technologies from $145.00 to $135.00 and set an “underweight” rating on the stock in a report on Wednesday. Citigroup upped their price objective on Agilent Technologies from $150.00 to $165.00 and gave the stock a “buy” rating in a research note on Thursday, August 22nd. Finally, Evercore ISI raised their target price on Agilent Technologies from $135.00 to $145.00 and gave the company an “in-line” rating in a research note on Tuesday, October 1st. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $143.40.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.